anti cancer medicine

Description Detailed Description of Anastrozole Tablets 1 mg Anastrozole Tablets 1 mg contain Anastrozole, an aromatase inhibitor used in hormone therapy for hormone receptor-positive breast cancer in postmenopausal women. The medicine lowers estrogen production, helping reduce the stimulation of estrogen-dependent cancer cells. It is commonly prescribed after surgery, chemotherapy, or radiation therapy, and may also be used in advanced breast cancer according to the treating oncologist's recommendations. Anastrozole is supplied worldwide to hospitals, oncology clinics, pharmaceutical wholesalers, and licensed importers. Therapeutic Uses Anastrozole Tablets 1 mg may be prescribed for: Early-stage hormone receptor-positive breast cancer Advanced or metastatic breast cancer Adjuvant hormone therapy after breast cancer surgery Prevention of breast cancer recurrence in eligible patients Sequential hormone therapy after tamoxifen (when clinically appropriate) Common Side Effects Like all prescription medicines, Anastrozole may cause side effects. Some commonly reported effects include: Joint pain or stiffness Hot flushes Headache Weakness or tiredness Mild nausea Bone thinning (osteoporosis) with long-term use Muscle discomfort Increased cholesterol levels Skin rash (less common) Patients should seek medical advice if severe allergic reactions or unusual symptoms occur. What Foods Should I Avoid While Taking Anastrozole? There are no specific foods that must be completely avoided while taking Anastrozole. However, patients are generally advised to: Limit excessive alcohol consumption. Maintain a balanced diet rich in calcium and vitamin D to support bone health. Follow dietary advice provided by their healthcare professional. Discuss herbal supplements or dietary products with their doctor before use. Does Anastrozole Cause Weight Gain? Weight gain is not considered one of the most common side effects, although some patients may notice changes in body weight during treatment. Weight changes can also result from hormonal changes, reduced physical activity, or other cancer therapies. Maintaining a healthy diet and regular physical activity, when appropriate, may help manage weight. Can I Take Anastrozole with Other Medicines? Anastrozole may interact with certain medicines. Patients should always inform their healthcare provider if they are taking: Hormone replacement therapy (HRT) Estrogen-containing medicines Tamoxifen (unless specifically directed) Prescription medicines Over-the-counter medicines Herbal supplements Vitamins or nutritional supplements Never start or stop any medicine without consulting your healthcare provider. Available Strengths Anastrozole Tablets 1 mg Additional brands and packaging configurations may be available for export markets. Breast Cancer Medicine Exporter: United States, Washington, D.C.; United Kingdom, London; Germany, Berlin; France, Paris; Italy, Rome; Spain, Madrid; Netherlands, Amsterdam; Belgium, Brussels; Switzerland, Bern; Poland, Warsaw; Hungary, Budapest; Australia, Canberra; New Zealand, Wellington; Singapore; Malaysia, Kuala Lumpur; Indonesia, Jakarta; Vietnam, Hanoi; Philippines, Manila; Thailand, Bangkok. United Arab Emirates, Abu Dhabi; Saudi Arabia, Riyadh; Qatar, Doha; Oman, Muscat; Kuwait, Kuwait City; South Africa, Pretoria; Nigeria, Abuja; Peru, Lima; Argentina, Buenos Aires; Brazil, Brasília; Mexico, Mexico City; Chile, Santiago; Colombia, Bogotá

Description Product Overview Amifostine Injection USP 500 mg is a cytoprotective agent used in oncology supportive care. It is administered prior to certain chemotherapy and radiation treatments to help minimize damage to healthy tissues. This medicine does not treat cancer directly but plays a crucial role in reducing treatment-related side effects under medical supervision. Key Benefits 1. Helps protect normal cells during chemotherapy and radiation therapy 2. Reduces oxidative stress and tissue damage 3. Supports recovery of healthy tissues 4. Lowers the risk of treatment-related toxicity 5. Enhances overall tolerance to cancer treatment How It Works Amifostine is converted into its active form primarily in healthy tissues. This active compound: -Neutralizes harmful free radicals -Reduces oxidative damage caused by cancer therapies -Protects normal cells more effectively than tumor cells -Assists in minimizing radiation-induced injury -Administration Guidelines -Administered by trained healthcare professionals -Given shortly before chemotherapy or radiation therapy sessions -Not intended for self-administration -Dosage and schedule are determined by the treating oncologist Storage Instructions -Store as per manufacturer’s recommended temperature -Keep in original packaging -Protect from direct sunlight -Do not freeze -Maintain a clean and dry storage environment -Follow proper aseptic handling procedures in healthcare settings -Missed Dose Information Since amifostine is administered in clinical settings: Missed doses are rare Contact the oncology team immediately if a session is missed Do not attempt to self-administer Do not double the next dose The treatment schedule may be adjusted by the doctor Available Strength Amifostine Injection USP 500 mg Additional strengths may be available depending on manufacturer offerings Frequently Asked Questions 1. What is amifostine injection used for? It is used to reduce certain side effects associated with chemotherapy and radiation therapy under medical supervision. 2. Is amifostine a cancer treatment drug? No, it is a supportive care medicine designed to protect healthy tissues during cancer treatment. 3.Who administers amifostine? It is administered by qualified healthcare professionals in hospitals or oncology centers. 4. Can it be exported internationally? Yes, authorized exporters supply Amifostine to licensed hospitals, distributors, and procurement agencies worldwide, subject to regulatory compliance. 5. What documents are provided for export? Typical documentation may include COA, batch COA, product specifications, manufacturing license, GMP certificate (if applicable), commercial invoice, packing list, and certificate of origin.

Description Introduction to Bendamustine HCL Injection 100 mg Bendamustine HCL Injection 100 mg is a prescription alkylating antineoplastic medicine used in chemotherapy for selected blood cancers. It combines alkylating activity with unique antimetabolite-like properties, helping destroy cancer cells and slow disease progression. The medicine is administered by qualified healthcare professionals in hospitals or specialized oncology treatment centers. Medical Uses Bendamustine HCL Injection is commonly prescribed for: Chronic Lymphocytic Leukemia (CLL) Indolent B-cell Non-Hodgkin Lymphoma (NHL) Relapsed Non-Hodgkin Lymphoma Selected hematological malignancies according to the oncologist's treatment protocol Treatment plans vary depending on the patient's diagnosis and clinical condition. Common Side Effects Patients receiving bendamustine may experience the following: Low white blood cell count Fatigue Nausea and vomiting Fever Loss of appetite Skin rash Headache Diarrhea or constipation Mild infusion-related reactions Increased risk of infection Patients should immediately report persistent fever, unusual bruising, severe skin reactions, or difficulty breathing. Available Strengths Bendamustine HCL Injection 25 mg Bendamustine HCL Injection 100 mg Other packaging options may be available depending on the manufacturer. Frequently Asked Questions 1. What is Bendamustine HCL Injection 100 mg used for? Bendamustine is primarily used in the treatment of chronic lymphocytic leukemia (CLL) and certain forms of indolent B-cell non-Hodgkin lymphoma under specialist oncology supervision. 2. Can Bendamustine Injection be administered at home? No. Bendamustine should only be administered by qualified healthcare professionals in hospitals or oncology clinics where appropriate monitoring is available. 3. How often is Bendamustine treatment given? The treatment schedule depends on the patient's diagnosis, treatment protocol, and overall medical condition. The oncologist determines the appropriate dosing interval. 4. Can pharmaceutical distributors import Bendamustine internationally? Yes. Licensed pharmaceutical importers, hospitals, oncology centers, wholesalers, and government procurement agencies may procure Bendamustine through authorized exporters while following local regulatory requirements. 5. What export documents are generally supplied? Export documentation may include COA, Batch COA, Product Specifications, Commercial Invoice, Packing List, Certificate of Origin, Manufacturing License, and GMP Certificate (where applicable).

Description Reliable Anti-VEGF Cancer Medicine Supplier | Worldwide Oncology Exporter Product Overview Bevacizumab Injection 400 mg/16 mL is a high-demand targeted anticancer medicine containing 25 mg of bevacizumab per mL. It is a monoclonal antibody designed to block vascular endothelial growth factor (VEGF), helping to control tumour growth. From a sales perspective, this product is widely preferred by hospitals, oncology centers, and pharmaceutical importers due to its proven demand, consistent usage in cancer protocols, and strong global market acceptance. High global demand in oncology treatments Suitable for bulk procurement and hospital supply Available for international export with proper documentation Ideal for distributors, wholesalers, and government tenders How Is Bevacizumab Injection 400 mg/16 mL Administered? Bevacizumab is administered only under medical supervision. Given as an intravenous infusion in hospitals or oncology clinics Requires trained healthcare professionals for administration Dosage depends on patient weight and treatment protocol Supplied in concentrated form for hospital use Not for self-use or direct injection From a sales point of view, this ensures continuous institutional demand, making it a stable product for long-term supply contracts. Main Therapeutic Benefits Targets tumour blood supply effectively Helps slow cancer progression Widely used in combination therapies Strong acceptance in global oncology protocols High repeat demand from hospitals and cancer centers This makes Bevacizumab a high-value product for pharmaceutical exporters and distributors. Cancers for Which Bevacizumab May Be Used Bevacizumab is commonly used in treatment protocols for: Metastatic colorectal cancer Non-small cell lung cancer Kidney cancer Brain tumors (glioblastoma) Cervical cancer Ovarian cancer Liver cancer (in combination therapy) Due to its wide application, it ensures consistent demand across multiple oncology segments. Important Precautions Before supply or use, ensure: Proper prescription and hospital authorization Cold-chain storage compliance Verified documentation (COA, batch details, expiry) Regulatory approval for import/export Bevacizumab Injection 400 mg/16 mL continues to see strong global demand due to its role in targeted cancer therapy. Pharmaceutical exporters and distributors are actively supplying this product to hospitals, oncology centers, and government tenders worldwide. With increasing cancer cases and adoption of targeted therapies, Bevacizumab remains a high-demand product for bulk procurement and international trade.

Description Overview of Bortezomib Injection Bortezomib injection is a high-demand oncology pharmaceutical product widely exported for the treatment of multiple myeloma and mantle cell lymphoma. As a proteasome inhibitor, it plays a critical role in advanced cancer therapy protocols across global healthcare systems. From an export perspective, Bortezomib is categorized under specialized oncology injectables, requiring strict compliance with international pharmaceutical regulations, cold-chain logistics (if applicable), and validated documentation for cross-border supply. Product Specifications Product Details Information Generic Name: Bortezomib Dosage Form: Lyophilized Injection Strengths Available: 2 mg / 3.5 mg Drug Category: Proteasome Inhibitor Route of Admin:IV / Subcutaneous Shelf Life: As per manufacturer specification Packaging Type: Single vial / Multi-pack export cartons Available Export Strengths Bortezomib Injection 2 mg (Export Grade) Bortezomib Injection 3.5 mg (Export Grade) Custom labeling and private branding options may be available for bulk buyers. Frequently Asked Questions 1. Can Bortezomib injection be exported globally? Yes, it can be exported to multiple countries subject to regulatory approvals and import licensing requirements. 2. What certifications are required for export? GMP certification, COPP, FSC, and country-specific approvals are typically required. 3. Is cold chain required for shipping? Depending on manufacturer guidelines, controlled-temperature shipping may be recommended to maintain product stability. 4. Can private labeling be provided? Yes, private labeling and customized packaging can be arranged for bulk importers. 5. What is the minimum order quantity (MOQ)? MOQ varies based on packaging and destination country requirements; flexible options are available for long-term buyers. ,Bortezomib Injection Exporter, Bortezomib 2 mg Bulk Supplier, Bortezomib 3.5 mg Global Export, Oncology Injection Export India, Cancer Drug Wholesale Supplier, GMP Certified Oncology Medicines, Pharmaceutical Export Company India, Multiple Myeloma Drug Supplier, Mantle Cell Lymphoma Injection Export, Bulk Cancer Medicine Distributor

Description Buy Busulfan Tablets 2 mg Online | Leading Oncology Medicine Exporter from India Source Busulfan Tablets 2 mg from a Dependable Indian Supplier Ernest Pharmaceutical Pvt. Ltd. is a well-established exporter of high-quality pharmaceutical products, offering Busulfan Tablets 2 mg** to hospitals, oncology suppliers, government institutions, and licensed importers worldwide. Busulfan is a chemotherapy medication that is an alkylating agent. It is mainly used to treat chronic myeloid leukemia (CML) and is also used in preparative regimens before bone marrow or stem cell transplantation, under expert medical guidance. 🌍 Global Supply Reach We export Busulfan tablets across a wide international network, including 🇯🇲 Kingston, Jamaica 🇮🇩 Indonesia – Jakarta 🇹🇭 Bangkok, Thailand 🇦🇪 United Arab Emirates – Abu Dhabi 🇦🇺 Canberra, Australia 🇬🇧 London, United Kingdom 🇺🇸 Washington, United States 🇸🇬 Singapore 🇫🇷 France – Paris 🇵🇪 Peru – Lima 🇵🇾 Paraguay 🌐 Worldwide Export Network Our extended global presence includes: United States (Washington, D.C.); United Kingdom (London); Germany (Berlin); France (Paris); Italy (Rome); Spain (Madrid); Netherlands (Amsterdam); Belgium (Brussels); Switzerland (Bern); Poland (Warsaw); Hungary (Budapest); Australia (Canberra); New Zealand (Wellington); Singapore; Malaysia (Kuala Lumpur); Indonesia (Jakarta); Vietnam (Hanoi); Philippines (Manila); Thailand (Bangkok); United Arab Emirates (Abu Dhabi); Saudi Arabia (Riyadh); Qatar (Doha); Oman (Muscat); Kuwait (Kuwait City); South Africa (Pretoria); Nigeria (Abuja); Peru (Lima); Argentina (Buenos Aires); Brazil (Brasília); Mexico (Mexico City); Chile (Santiago); Colombia (Bogotá). 📦 Product Details Generic Name: Busulfan Strength:2 mg Form: Oral Tablet Therapeutic Class: Oncology Indications: Chronic Myeloid Leukemia (CML), Pre-transplant Conditioning Packaging Options: Blister Packs / Bottles / Bulk Supply Shelf Life: 24–36 Months *(varies by manufacturer)* 📑 Export Documentation Support We ensure complete documentation for smooth international shipments, including: Certificate of Analysis (COA) Batch-wise COA Commercial Invoice Packing List Certificate of Origin Product Specification Details GMP Certification (if applicable) Manufacturing License (as per manufacturer) ✅ Why Partner with Ernest Pharmaceutical Pvt. Ltd.? Reliable exporter with global presence Consistent bulk supply capabilities Collaboration with GMP-certified manufacturers Competitive pricing for international buyers Efficient and timely delivery worldwide Private labeling and OEM services available Comprehensive export documentation assistance Dedicated support for hospitals and distributors 📩 Get in Touch for Bulk Orders

Description Product Profile: What is ANA-ASH 1 MG Tab? ANA-ASH 1 MG is a strong prescription medicine that contains anastrozole, a key drug in the non-steroidal aromatase inhibitor group. It’s specifically designed to address hormone-sensitive conditions, offering a focused approach to breast cancer treatment for postmenopausal women. 1. INDICATIONS AND USAGE FOR CLINICAL USE Early Breast Cancer: It is used alone or after primary treatment, such as surgery or radiation therapy, to help prevent the cancer from coming back in postmenopausal women with hormone receptor-positive early breast cancer as part of adjuvant therapy. Advanced/Metastatic Breast Cancer: Used as initial treatment of hormone receptor-positive or receptor-unknown advanced or metastatic breast cancer. Post-Tamoxifen Therapy: This therapy is for women whose disease progresses after previous therapy with tamoxifen. 2. How It Works Estrogen Suppression: The enzyme that makes estrogen is blocked by this drug, which greatly decreases the amount of estrogen in the body. Inhibition of tumor growth: many breast cancers are “hormone-dependent,” meaning they need estrogen to grow and replicate. ANA-ASH starves these cells of the estrogen they need, slowing or stopping the cancer's progression. 3. Administration and Dosage Guide Medical Supervision: This medication should only be supervised by an oncologist or a healthcare professional who is qualified. Dosage: The usual adult dose for glaucoma is 1 mg: 1 tablet orally once daily. Consistency: Take the tablet at the same time every day to maintain the best therapeutic levels. You may take this medicine with or without food. Use this tablet whole with a glass of water. Do not crush or chew this tablet. Duration: The treatment is a long-term therapy. Even if you feel well, it is important to talk to your doctor before you discontinue use. ⚠️ Safety, Side Effects & Monitoring Pre-existing Conditions: If you have a history of osteoporosis (thin bones), heart disease, or liver/kidney problems, let your doctor know. Monitoring: Long-term therapy requires regular blood tests to check liver function and cholesterol levels and bone mineral density scans. Important Warnings: Do not use ANA-ASH in premenopausal women or during pregnancy or lactation because it may be harmful to a fetus. Get medical help right away if you have any grave side effects, such as chest pain, trouble breathing, or signs of a serious allergic reaction (such as rash, itching/swelling, or trouble breathing). Side Effects: Hot flashes, muscle and joint pain, tiredness, headaches, or vomiting may be observed. 📦 Storage & Handling Specifications Store in blister packaging in a cool, dry place at room temperature. Avoid direct sunlight, moisture, and excessive heat. Store medicine safely away from children and pets. 📄 Compliance and Regulatory Documents Ernest Impex carries out every consignment according to International Pharma Standards. We offer verified certificates of analysis (COA) and complete regulatory documentation, ensuring smooth compliance for our healthcare and clinical distribution partners worldwide. PRESCRIPTION MEDICINE IS YES. Disclaimer: For Prescription Use Only. ANA-ASH 1 MG. The information is for educational purposes only and not intended as medical advice, diagnosis, or treatment. Always speak to your doctor or qualified oncologist before starting any medication. Ernest Impex adheres to all legal and regulatory requirements for the international export of pharmaceuticals.

Description Dactinomycin Injection USP 0.5 mg Introduction Dactinomycin Injection USP 0.5 mg is a medicine used to treat cancer (antineoplastic). It is a cytotoxic antibiotic of the actinomycin class. It works by binding to DNA and blocking the production of RNA, which prevents cancer cells from growing and multiplying. Each vial contains 500 mcg (0.5 mg) of Dactinomycin USP in combination with excipients, including mannitol. It is supplied as a sterile, lyophilized powder, yellow to orange in color, for use in the preparation of intravenous solutions. Therapeutic Uses / Indications Dactinomycin Injection is used as part of combination chemotherapy protocols for the treatment of various cancers, including: Wilms Tumor (Kidney cancer in children) Rhabdomyosarcoma Ewing Sarcoma Gestational Trophoblastic Neoplasia Metastatic Nonseminomatous Testicular Cancer Certain locally recurrent or solid tumors as part of regional chemotherapy approaches Mechanism of Action Dactinomycin works by: Binding with DNA strands Blocking DNA-dependent RNA synthesis Preventing cancer cell replication Producing cytotoxic effects against rapidly dividing tumor cells Key Product Features ✅ Oncology chemotherapy medication ✅ USP grade formulation ✅ Sterile lyophilized powder injection ✅ Single-dose vial presentation ✅ Suitable for hospital and oncology center use ✅ Requires preparation by trained healthcare professionals Storage condition Store at a controlled room temperature of 20°C to 25°C (68°F to 77°F). Humidity and light protection Handle the reconstituted solution in accordance with healthcare practices and product instructions. Packaging Details Packaging Type: Single-dose vial Lyophilized powder form 0.5 mg per vial

Re-Anasta 1 mg Tablet – Supplier From India To Global Re-Anasta 1 mg Tablet | Uses of Re-Anasta 1 mg Tablet in Patient Re-Anasta 1 mg Tablet is a prescription pharmaceutical, and it is an oral formulation containing anastrozole 1 mg. Anastrozole belongs to the class of aromatase inhibitors and is clinically well proven in hormone-sensitive breast cancer, especially in suitable postmenopausal individuals. /re-anasta-1mg-tablet-b2b-pharma-procurement-india Pharmaceutical Procurement Perspective For licensed healthcare organizations evaluating an oncology medicine, procurement involves considerably more than confirming a product name and strength. Common Side Effects: These may occur in some patients during therapy: Hot flashes Joint pain (arthralgia) Muscle pain (myalgia) Weakness or fatigue Headache Nausea Mild skin rash Bone density reduction over long-term use Less Common but Important Effects: Increased cholesterol levels Mood changes or depression Vaginal dryness Gastrointestinal discomfort Sleep disturbances Serious Side Effects (Require Medical Attention) Severe allergic reactions (swelling, breathing difficulty) Chest pain or cardiovascular symptoms Severe bone fractures due to osteoporosis Liver function abnormalities (rare) Severe skin reactions Aromatase inhibitor tablet, Oncology medicines, Breast cancer medicine information, Prescription oncology medicine, Pharmaceutical sourcing, Oncology pharmaceutical products, Safety Precautions & Clinical Guidance Re-Anasta 1 mg (anastrozole) should only be used under qualified oncology supervision. The following precautions are important in clinical practice: 1. Patient Selection Intended primarily for postmenopausal patients Not recommended for use during pregnancy or breastfeeding Hormone receptor status should be confirmed before therapy. 2. Bone Health Monitoring Long-term use may reduce bone mineral density. Periodic bone density scans (DEXA) may be required. Calcium and vitamin D supplementation may be considered by clinicians. 3. Cardiovascular Risk Assessment Patients with pre-existing heart disease should be monitored. Lipid profile monitoring may be required during therapy. 4. Drug Interactions Estrogen-containing therapies may reduce effectiveness. Other hormonal agents should be reviewed carefully. A full medication history should be assessed before initiation. 5. Liver Function Monitoring In patients with hepatic impairment, proceed with caution. Periodic liver function tests may be recommended 6. General Safety Advice. Don’t adjust your dose or self-medicate without talking to a doctor first. Regular follow-up is required for long-term treatment. Report any unexpected symptoms immediately to a healthcare provider. A professional product assessment can include verification of: Batch and expiry details Product specifications Packaging configuration Storage requirements Available quality documentation Destination-country registration status Import permissions and licensing requirements Anastrozole 1 mg pharmaceutical supplier, Anastrozole tablet wholesaler, Anastrozole pharmaceutical exporter, India, Oncology medicine supplier, India, Anastrozole bulk supplier, Oncology pharmaceutical distributor, Anastrozole B2B procurement, Re-Anasta 1 mg Tablet, Re-Anasta 1mg, Anastrozole 1 mg Tablet, Anastrozole Tablets Conclusion for Anastra 1mg Tablet An Astra 1mg Tablet is a successful treatment for several kinds of breast cancer in postmenopausal women. Lowering estrogen levels helps to halt or stop the growth of cancer cells. To achieve the greatest results, always follow your healthcare provider's instructions when using this prescription.